Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Horstink

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Clinical Neurology and Neurosurgery|January 1, 1984
Problems of levodopa treatmentM W Horstink
Neurology|August 26, 1998
Suprathreshold levodopa doses, dyskinesias, and disability in advanced Parkinson's diseaseM W Horstink, P Praamstra
Acta Neuropathologica|January 1, 1993
Striatonigral degeneration with neurofibrillary tanglesK Renkawek, M W Horstink
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1994
Parkinsonism due to a subdural hematomaA T Hageman, M W Horstink
Advances in Neurology|July 20, 1999
Preclinical diagnosis of Parkinson's diseaseM W Horstink, P K Morrish
Neurology|October 1, 1991
L-dopa in Parkinson's diseaseM W Horstink, C J van de Vlasakker
Molecular Aspects of Medicine|January 1, 1997
Q10 therapy in patients with idiopathic Parkinson's diseaseE Strijks, H P Kremer, M W Horstink
Experimental Brain Research|March 16, 2000
Redundant-signals effects on reaction time, response force, and movement-related potentials in Parkinson's diseaseF M Plat, P Praamstra, M W Horstink
Clinical Neuropharmacology|April 15, 1999
Effects of female sex steroids on Parkinson's disease in postmenopausal womenE Strijks, J A Kremer, M W Horstink
Clinical Neuropharmacology|October 1, 1993
Short-term memory in Parkinson's disease after withdrawal of long-term anticholinergic therapyG van Herwaarden, H J Berger, M W Horstink
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Clinical Neurology and Neurosurgery|January 1, 1984
Problems of levodopa treatmentM W Horstink
Neurology|August 26, 1998
Suprathreshold levodopa doses, dyskinesias, and disability in advanced Parkinson's diseaseM W Horstink, P Praamstra
Acta Neuropathologica|January 1, 1993
Striatonigral degeneration with neurofibrillary tanglesK Renkawek, M W Horstink
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1994
Parkinsonism due to a subdural hematomaA T Hageman, M W Horstink
Advances in Neurology|July 20, 1999
Preclinical diagnosis of Parkinson's diseaseM W Horstink, P K Morrish
Neurology|October 1, 1991
L-dopa in Parkinson's diseaseM W Horstink, C J van de Vlasakker
Molecular Aspects of Medicine|January 1, 1997
Q10 therapy in patients with idiopathic Parkinson's diseaseE Strijks, H P Kremer, M W Horstink
Experimental Brain Research|March 16, 2000
Redundant-signals effects on reaction time, response force, and movement-related potentials in Parkinson's diseaseF M Plat, P Praamstra, M W Horstink
Clinical Neuropharmacology|April 15, 1999
Effects of female sex steroids on Parkinson's disease in postmenopausal womenE Strijks, J A Kremer, M W Horstink
Clinical Neuropharmacology|October 1, 1993
Short-term memory in Parkinson's disease after withdrawal of long-term anticholinergic therapyG van Herwaarden, H J Berger, M W Horstink
Pageof 8